1. The growing concept of green dialysis: how to heal our sick dialysis wards?

   • Giorgina Barbara Piccoli
   • on behalf of the Green nephrology working group of the Italian Society of Nephrology

   Editorial 04 April 2023 Pages: 595 - 598

   

2. The day the earth shook

   • Siren Sezer
   • Serhan Tuglular
   • Alaattin Yildiz

   Editorial 05 April 2023 Pages: 599 - 600

   

3. Risks of in-hospital death and hospital length of stay of 7 days or longer among end-stage renal disease patients hospitalized with COVID-19: a retrospective cohort study in five California medical centers

   • Marc Reiterman
   • Robert Atwill
   • Andrew I-Wei Chin

   Research Letter 04 April 2023 Pages: 601 - 603

4. Post-mortem renal histopathological findings in 43 COVID-19 patients with acute kidney injury (AKI) deceased in the intensive care unit

   • Anna Augusta Maria Perego
   • Gianmarco Sabiu
   • Manuela Nebuloni

   Research Letter 13 February 2023 Pages: 605 - 608

   

5. Antibody levels following booster SARS-CoV-2 vaccination among dialysis patients initially vaccinated with adenovirus vector-based vaccine

   • Joanna Willetts
   • Linda H. Ficociello
   • Jeffrey L. Hymes

   Research Letter Open access 23 January 2023 Pages: 609 - 611

   

6. Graft function and health status in renal transplant recipients hospitalized for COVID-19: a single center case series

   • Benjamin Giszas
   • Johannes Ruhe
   • Gunter Wolf

   Research Letter Open access 05 September 2022 Pages: 613 - 615

   

7. Is there a link between COVID-19 and adrenal insufficiency?

   • Carlos Augusto Pereira de Almeida
   • Marilia Rodovalho Guimarães
   • Lúcia da Conceição Andrade

   Research Letter 23 August 2022 Pages: 617 - 619

8. Negative prognostic impact of electrolyte disorders in patients hospitalized for Covid-19 in a large multicenter study

   • Simonetta Genovesi
   • Giuseppe Regolisti
   • Maria Grazia Valsecchi

   Research Letter 24 August 2022 Pages: 621 - 626

   

9. Salt-losing tubulopathy worsening the prognosis of renal sarcoidosis

   • Anis Abu Ayyach
   • Alain Le Moine
   • Joëlle Nortier

   Lessons for the Clinical Nephrologist Open access 16 January 2023 Pages: 627 - 630

   

10. Biopsy-proven acute interstitial nephritis after SARS-CoV-2 mRNA vaccination—adverse vaccine side effect or unrelated complication from self-medication? Lessons for the clinical nephrologist

    • Peter Schnuelle
    • Constantin Schwab
    • Christian Bischofs

    Lessons for the Clinical Nephrologist 21 November 2022 Pages: 631 - 633

    

11. ANCA-negative pauci-immune crescentic glomerulonephritis associated with Fabry disease: lesson for the clinical nephrologist

    • Charles Ronsin
    • Lola Jacquemont
    • Simon Ville

    Lessons for the Clinical Nephrologist 16 February 2023 Pages: 635 - 638

    

12. Renal biopsy diagnosis of IgG4-related kidney disease with minor hematuria and mild renal dysfunction: lessons for the clinical nephrologist

    • Yu Soma
    • Miku Kato
    • Maki Iida

    Lessons for the Clinical Nephrologist 28 November 2022 Pages: 639 - 642

    

13. Polycystic kidney disease associated with intracranial hypertension revealing a mutation of the OFD1 gene

    • Céline Schultz
    • Jean Chiesa
    • Olivier Moranne

    Lessons for the Clinical Nephrologist 26 December 2022 Pages: 643 - 645

    

14. Thrombotic thrombocytopenic purpura after vaccination for COVID-19: lesson for the clinical nephrologist

    • Fedai Özcan
    • Alexandra Brinkhoff
    • Markus Hollenbeck

    Lessons for the Clinical Nephrologist 01 October 2022 Pages: 647 - 649

15. Clinical features suggesting renal hypouricemia as the cause of acute kidney injury: a case report and review of the literature

    • Tommaso Mazzierli
    • Luigi Cirillo
    • Francesca Becherucci

    Case Report Open access 23 November 2022 Pages: 651 - 657

    

16. Focal segmental glomerulosclerosis in a patient with multiple sclerosis treated with Teriflunomide and Ocrelizumab

    • Anne-Sofie Greve
    • Sivagini Prakash
    • Else Randers

    Case Report 21 November 2022 Pages: 659 - 661

    

17. The first case of lipoprotein glomerulopathy complicated with collagen type III glomerulopathy and literature review

    • Huixia Liu
    • Changqing Luo
    • Jing Xiong

    Case Report Open access 12 November 2022 Pages: 663 - 667

    

18. Sotrovimab in SARS-COV-2 chronic hemodialysis patients in the Omicron era. Is intradialytic administration feasible? Report of 4 cases

    • Emanuele Mambelli
    • Lorenzo Gasperoni
    • Angelo Rigotti

    Case Report 13 September 2022 Pages: 669 - 672

19. Osmotic nephrosis after intravenous contrast media

    • Mineaki Kitamura
    • Edward Calomeni
    • Anjali A. Satoskar

    Art in the Ward 23 November 2022 Pages: 673 - 674

    

20. Adhesive intestinal obstruction resulting from peritoneal dialysis

    • Zhigang Ke
    • Li Wang
    • Weidong Tong

    Art in the Ward 27 September 2022 Pages: 675 - 676

    

21. Reassessing the utility of access recirculation and Kt/V for the prediction of arteriovenous fistula failure using online clearance monitoring: the SHUNT STUDY

    • Richard Bodington
    • Adil M. Hazara
    • Sunil Bhandari

    Original Article 29 November 2022 Pages: 677 - 686

    

22. Comparison between FRAIL Scale and Clinical Frailty Scale in predicting hospitalization in hemodialysis patients

    • Elisabete Mouzinho Soares Barbosa
    • Amanda Gomes Pereira
    • Mariana de Souza Dorna

    Original Article 22 December 2022 Pages: 687 - 693

    

23. Usefulness of urinary calprotectin as a novel marker differentiating functional from structural acute kidney injury in the critical care setting

    • Jomol Sara John
    • R. V. Deepthi
    • Indira Agarwal

    Original Article 21 February 2023 Pages: 695 - 704

    

24. Novel glucose-lowering drugs and the risk of acute kidney injury in routine care; the Stockholm CREAtinine Measurements (SCREAM) project

    • Jim Alkas
    • Alessandro Bosi
    • Juan Jesus Carrero

    Original Article Open access 02 December 2022 Pages: 705 - 711

    

25. Role of sodium-glucose cotransporter-2 inhibitors in risk of chronic kidney disease among patients with type 2 diabetes mellitus

    • Tung-Sheng Chen
    • Teng-Shun Yu
    • Wei-Syun Hu

    Original Article 19 December 2022 Pages: 713 - 718

    

26. A nomogram based on shear wave elastography for assessment of renal fibrosis in patients with chronic kidney disease

    • Ziman Chen
    • Jiaxin Chen
    • Zhongzhen Su

    Original Article 18 November 2022 Pages: 719 - 729

    

27. Sustained employment, work disability and work functioning in CKD patients: a cross-sectional survey study

    • Manna A. Alma
    • Sijrike F. van der Mei
    • Annemieke Visser

    original Article Open access 31 October 2022 Pages: 731 - 743

    

28. Self-rated health and the risk of incident chronic kidney disease: a community‐based Korean study

    • Hyun-Lee Ko
    • Hyang-Ki Min
    • Sung-Woo Lee

    original Article 07 December 2022 Pages: 745 - 753

    

29. Magnesium Depletion Score is Associated with Long-Term Mortality in Chronic Kidney Diseases: A Prospective Population-Based Cohort Study

    • Saifu Yin
    • Zhaoxia Zhou
    • Xianding Wang

    original Article 15 November 2022 Pages: 755 - 765

    

30. Risk improvement and adverse kidney outcomes in patients with chronic kidney disease: findings from KNOW-CKD

    • Hee Byung Koh
    • Hyung Woo Kim
    • the KoreaN cohort study for Outcomes in patients With Chronic Kidney Disease (KNOW-CKD) Investigators

    original Article 24 November 2022 Pages: 767 - 776

    

31. Ethnic disparities in pregnancy-related acute kidney injury in a United Kingdom population

    • Rouvick M. Gama
    • Mahua Bhaduri
    • Kate Bramham

    Original Article 13 January 2023 Pages: 777 - 787

    

32. Relationship between anti-GBM antibodies and kidney outcomes in patients with anti-GBM disease

    • Mengyue Zhu
    • Jingjing Wang
    • Haitao Zhang

    original Article 24 November 2022 Pages: 789 - 797

    

33. Leukocyturia and hematuria enable non-invasive differentiation of Bowman’s capsule rupture severity in PR3-ANCA glomerulonephritis

    • Eva Baier
    • Ingmar Alexander Kluge
    • Björn Tampe

    Original Article Open access 21 December 2022 Pages: 799 - 808

    

34. Genome-wide association study biomarkers in T-cell mediated rejection: selective effect according to the Banff classification

    • Jose Luis Santiago
    • Luis Sánchez-Pérez
    • Ana Isabel Sánchez-Fructuoso

    original Article 10 August 2022 Pages: 809 - 815

    

35. Clinical characteristics and outcomes of a patient population with atypical hemolytic uremic syndrome and malignant hypertension: analysis from the Global aHUS registry

    • Jean-Michel Halimi
    • Imad Al-Dakkak
    • Eric Rondeau

    Original Article Open access 24 September 2022 Pages: 817 - 828

    

36. Induction therapy for pediatric onset class IV lupus nephritis: Mycophenolate Mofetil versus Cyclophosphamide

    • Marwa Chbihi
    • Laurye-Anne Eveillard
    • Olivia Boyer

    original Article 08 October 2022 Pages: 829 - 839

    

37. Waiting for a kidney transplant, a source of unavoidable but reversible anxiety: a prospective pilot study investigating a psychological intervention

    • Emmanuelle Courtillié
    • Benoit Fromage
    • Angélique Bonnaud-Antignac

    Original Article 21 January 2023 Pages: 841 - 849

    

38. Sex differences in COVID-19 symptoms and outcomes in people with kidney failure treated with dialysis: a prospective cohort study

    • Tyrone G. Harrison
    • Trinity A. Tam
    • Jennifer M. MacRae

    original Article 10 September 2022 Pages: 851 - 860

    

39. Assessment of the humoral response to the homologous Gam-COVID-Vac (Sputnik V) or heterologous Sputnik V/mRNA-1273 (Moderna) vaccination against SARS-CoV-2 in dialysis patients

    • Gustavo Laham
    • Alfredo P. Martínez
    • Federico Alejandro Di Lello

    original Article 24 September 2022 Pages: 861 - 872

    

40. Gut microbiota disturbances and protein-energy wasting in chronic kidney disease: a narrative review

    • Fabiola Martín-del-Campo
    • Carla Maria Avesani
    • Laura Cortés-Sanabria

    Review Open access 23 January 2023 Pages: 873 - 883

    

41. Endocrinological disorders in acute kidney injury: an often overlooked field of clinical research

    • Sidar Copur
    • Atalay Demiray
    • Mehmet Kanbay

    Review 18 January 2023 Pages: 885 - 893

    

42. Muscle fat infiltration in chronic kidney disease: a marker related to muscle quality, muscle strength and sarcopenia

    • Carla Maria Avesani
    • Aline Miroski de Abreu
    • Bengt Lindholm

    Review Open access 31 January 2023 Pages: 895 - 910

    

43. Noncoding RNAs associated with IgA nephropathy

    • Sangeetha P. Kademani
    • Prabhudas Nelaturi
    • Sambandam Ravikumar

    Review 10 December 2022 Pages: 911 - 923

    

44. COVID 19, Paxlovid and the lesson from rare genetic diseases with naturally occurring protection from SARS-CoV-2 infection

    • Lorenzo A. Calò
    • Luca Sgarabotto
    • Paul A. Davis

    Commentary 16 September 2022 Pages: 925 - 927

    

45. Electrolytes and COVID-19: challenges and caveats in clinical research studies

    • Simonetta Genovesi
    • Giuseppe Regolisti
    • MariaGrazia Valsecchi

    Commentary 18 August 2022 Pages: 929 - 931

46. Gird your kidneys? A novel approach to ADPKD therapeutics

    • Andrew Mallett

    Commentary 12 August 2022 Pages: 933 - 934

47. Waiting for a kidney transplant: less anxiety, more longing

    • Alina Seman
    • Rossella Picillo

    From the patients side 02 February 2023 Pages: 935 - 936